Manzo Pharmaceuticals, Inc.
OOTC:MNZOShare Statistics
As of December 31, 2004, Manzo Pharmaceuticals, Inc. has 3.49M shares outstanding.
| Shares Outstanding | 3.49M |
Financial Position
As of December 31, 2004, Manzo Pharmaceuticals, Inc. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.01 |
| Debt / Equity | -28.98 |
| Debt / EBITDA | -4.12 |
Income Statement
USDOver the twelve months ended December 31, 2004, Manzo Pharmaceuticals, Inc. generated - - in revenue and converted that into -2.05M in net income, yielding earnings per share of -0.59. EBITDA reached -1.58M, while operating income came in at -2.94M.
| Gross Profit | -27,773.00 |
| Operating Income | -2.94M |
| Net Income | -2.05M |
| EBITDA | -1.58M |
| EBIT | -1.58M |
| Earnings Per Share (EPS) | -0.59 |
Balance Sheet
USDAs of December 31, 2004, Manzo Pharmaceuticals, Inc. holds 9,776.00 in cash and equivalents against 6.52M in total debt, resulting in a net debt position of 6.51M. Total book value stands at -22.50M, with working capital of -23.65M providing operational flexibility.
| Cash & Cash Equivalents | 9,776.00 |
| Total Debt | 6.52M |
| Net Debt | 6.51M |
| Equity (Book Value) | -22.50M |
| Book Value Per Share | -6.45 |
| Working Capital | -23.65M |
Cash Flow
USDThese figures cover the twelve months ended December 31, 2004.
| Capital Expenditures | -1.00 |
Stock Splits
Manzo Pharmaceuticals, Inc.'s most recent stock split took place on September 17, 2014 with a 10:1 split ratio.
| Last Split Date | 9/17/2014 |
| Split Ratio | 10:1 |